• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯硝西泮在难治性惊恐障碍患者中的成功应用。

Successful use of clonazepam in patients with treatment-resistant panic disorder.

作者信息

Tesar G E, Rosenbaum J F

出版信息

J Nerv Ment Dis. 1986 Aug;174(8):477-82. doi: 10.1097/00005053-198608000-00006.

DOI:10.1097/00005053-198608000-00006
PMID:3734770
Abstract

Ten cases are presented--two in detail--in which clonazepam was used successfully in patients with treatment-resistant panic disorder with or without agoraphobia. Seven of 10 patients who had been resistant to standard pharmacological treatments of panic attacks and agoraphobia achieved cessation of their attacks while three had mild to moderate symptom persistence. These data underscore other reports of clonazepam's usefulness in the treatment of panic disorder. Clinical use of clonazepam is discussed.

摘要

本文介绍了10例病例——其中2例详细介绍——在这些病例中,氯硝西泮成功用于治疗伴有或不伴有广场恐惧症的难治性惊恐障碍患者。10例对惊恐发作和广场恐惧症的标准药物治疗耐药的患者中,有7例发作停止,3例仍有轻度至中度症状持续存在。这些数据强调了其他关于氯硝西泮治疗惊恐障碍有效性的报告。文中还讨论了氯硝西泮的临床应用。

相似文献

1
Successful use of clonazepam in patients with treatment-resistant panic disorder.氯硝西泮在难治性惊恐障碍患者中的成功应用。
J Nerv Ment Dis. 1986 Aug;174(8):477-82. doi: 10.1097/00005053-198608000-00006.
2
Clonazepam in the treatment of patients with recurrent panic attacks.
J Clin Psychiatry. 1986 Feb;47(2):83-5.
3
Treatment of panic disorder and agoraphobia with clonazepam.用氯硝西泮治疗惊恐障碍和广场恐惧症。
J Clin Psychiatry. 1986 May;47(5):238-42.
4
Clonazepam blockade of spontaneous and CO2 inhalation-provoked panic in a patient with panic disorder.氯硝西泮对一名惊恐障碍患者的自发性及吸入二氧化碳诱发的惊恐发作的阻断作用。
J Clin Psychiatry. 1986 Sep;47(9):475-6.
5
An open clinical trial of clonazepam in the treatment of patients with recurrent panic attacks.氯硝西泮治疗复发性惊恐发作患者的开放性临床试验。
Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):589-92. doi: 10.1016/0278-5846(85)90022-3.
6
A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.阿普唑仑与丙咪嗪治疗广场恐怖症和惊恐障碍的比较。
Psychopharmacol Bull. 1986;22(1):167-72.
7
Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up.氯硝西泮治疗惊恐障碍和广场恐惧症:一年随访
J Clin Psychopharmacol. 1986 Oct;6(5):302-4.
8
Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.对伴有惊恐发作的惊恐障碍和广场恐怖症患者使用苯乙肼的治疗反应。
J Clin Psychiatry. 1987 Feb;48(2):55-9.
9
Diazepam and propranolol in panic disorder and agoraphobia.
Arch Gen Psychiatry. 1984 Mar;41(3):287-92. doi: 10.1001/archpsyc.1984.01790140077009.
10
Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.阿普唑仑、普萘洛尔及安慰剂治疗惊恐障碍和伴有惊恐发作的广场恐怖症
J Clin Psychopharmacol. 1989 Feb;9(1):22-7.

引用本文的文献

1
Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review.在焦虑障碍中统一治疗抵抗的多种定义:系统综述。
Depress Anxiety. 2019 Sep;36(9):801-812. doi: 10.1002/da.22895. Epub 2019 Jun 23.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2018 Jan 15;48(1):64-153.
3
Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation.在两种惊恐发作激发大鼠模型中对新型脑渗透性选择性食欲素1受体拮抗剂JNJ-54717793的评估。
Front Pharmacol. 2017 Jun 9;8:357. doi: 10.3389/fphar.2017.00357. eCollection 2017.
4
OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES.食欲素1和2受体在二氧化碳诱发的惊恐相关行为及自主反应中的作用
Depress Anxiety. 2015 Sep;32(9):671-83. doi: 10.1002/da.22403. Epub 2015 Aug 19.
5
Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks.与意外、预期及实验室诱发的惊恐发作相关的病因、触发因素及神经化学回路。
Neurosci Biobehav Rev. 2014 Oct;46 Pt 3:429-54. doi: 10.1016/j.neubiorev.2014.07.027. Epub 2014 Aug 15.
6
An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus.一种伴有中脑背内侧/室旁核慢性去抑制的惊恐易损性动物模型。
Physiol Behav. 2012 Dec 5;107(5):686-98. doi: 10.1016/j.physbeh.2012.03.016. Epub 2012 Mar 26.
7
Algorithm for the pharmacotherapy of anxiety disorders.焦虑症的药物治疗算法
Curr Psychiatry Rep. 2003 Aug;5(4):282-8. doi: 10.1007/s11920-003-0057-6.
8
A risk-benefit assessment of pharmacological treatments for panic disorder.惊恐障碍药物治疗的风险效益评估。
Drug Saf. 1998 Jun;18(6):419-30. doi: 10.2165/00002018-199818060-00003.
9
Overview of panic disorder.惊恐障碍概述。
Trans Am Clin Climatol Assoc. 1994;105:36-51; discussion 51-3.